成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 496-15-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 496-15-1
Chemical Structure| 496-15-1
Structure of 496-15-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 496-15-1 ]

Related Doc. of [ 496-15-1 ]

Alternatived Products of [ 496-15-1 ]
Product Citations

Product Details of [ 496-15-1 ]

CAS No. :496-15-1 MDL No. :MFCD00005705
Formula : C8H9N Boiling Point : -
Linear Structure Formula :- InChI Key :LPAGFVYQRIESJQ-UHFFFAOYSA-N
M.W : 119.16 Pubchem ID :10328
Synonyms :

Calculated chemistry of [ 496-15-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.53
TPSA : 12.03 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.57
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 1.08
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 2.3
Consensus Log Po/w : 1.73

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.29
Solubility : 0.614 mg/ml ; 0.00515 mol/l
Class : Soluble
Log S (Ali) : -1.81
Solubility : 1.86 mg/ml ; 0.0156 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.95
Solubility : 0.134 mg/ml ; 0.00112 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.07

Safety of [ 496-15-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338-P210 UN#:N/A
Hazard Statements:H302-H315-H319-H335-H227 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 496-15-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 496-15-1 ]
  • Downstream synthetic route of [ 496-15-1 ]

[ 496-15-1 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 496-15-1 ]
  • [ 22949-08-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2005, vol. 40, # 2, p. 167 - 172
[2] Heterocycles, 1998, vol. 48, # 12, p. 2481 - 2484
[3] Zhurnal Obshchei Khimii, 1959, vol. 29, p. 2541,2550; engl. Ausg. S. 2504, 2511
  • 2
  • [ 496-15-1 ]
  • [ 143262-17-3 ]
Reference: [1] Heterocycles, 1992, vol. 34, # 5, p. 1031 - 1038
  • 3
  • [ 496-15-1 ]
  • [ 873055-33-5 ]
Reference: [1] Patent: US2011/98311, 2011, A1,
[2] Patent: US2012/309758, 2012, A1,
[3] Patent: US2015/231142, 2015, A1,
Recommend Products
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 496-15-1 ]

Indolines

Chemical Structure| 65673-86-1

[ 65673-86-1 ]

7-Methylindoline

Similarity: 0.95

Chemical Structure| 52537-01-6

[ 52537-01-6 ]

Indolin-4-amine

Similarity: 0.93

Chemical Structure| 6872-06-6

[ 6872-06-6 ]

2-Methylindoline

Similarity: 0.91

Chemical Structure| 1914-02-9

[ 1914-02-9 ]

3,3-Dimethylindoline

Similarity: 0.89

Chemical Structure| 22120-50-9

[ 22120-50-9 ]

2,3-Dimethylindoline

Similarity: 0.83

; ;